z-logo
Premium
Percutaneous valve implantation in “tricuspid” position after a Fontan‐Björk operation
Author(s) -
Mendes Inês C.,
MaymoneMartins Fernando,
Anjos Rui
Publication year - 2016
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.12853
Subject(s) - medicine , tricuspid atresia , tricuspid valve , percutaneous , cardiology , tricuspid stenosis , shunt (medical) , pulmonary atresia , surgery , stenosis , heart septal defect , heart disease
Background A 30‐year‐old female with tricuspid valve atresia, ventricular septal defect, and atrial septal defect had a neonatal modified Blalock Taussig shunt and a Fontan‐Björk operation performed at five years of age. She did well initially but progressively developed signs of systemic congestion due to severe homograft stenosis and underwent successful percutaneous implantation of a Melody ® pulmonary valve (Medtronic, Minneapolis, MN, USA) in the “tricuspid” position.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom